Dyne Therapeutics (DYN) Other Non Operating Income (2019 - 2026)

Dyne Therapeutics (DYN) has reported Other Non Operating Income for 8 consecutive years, with $3.1 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Other Non Operating Income fell 37.07% year-over-year to $3.1 million; the TTM figure through Jun 2026 stood at $17.6 million (down 37.41% YoY), while the FY2025 annual figure was $22.0 million, down 16.99% from the prior year.
• Other Non Operating Income declined to $3.1 million in Q2 2026 per DYN's latest filing, from $4.4 million in the prior quarter.
• Across five years, Other Non Operating Income topped out at $8.5 million in Q3 2024 and bottomed at $200000.0 in Q1 2022.
• Historically, Other Non Operating Income has averaged $3.6 million across 5 years, with a median of $3.3 million in 2024.
• Annual changes were most pronounced in 2022 — Other Non Operating Income soared 657.47% — and 2025, when it slumped 44.83%.
• Dyne Therapeutics' Other Non Operating Income stood at $1.3 million in 2022, then decreased by 20.33% to $1.0 million in 2023, then jumped by 620.57% to $7.6 million in 2024, then tumbled by 44.83% to $4.2 million in 2025, then declined by 25.61% to $3.1 million in 2026.
• Business Quant data shows DYN's Other Non Operating Income at $3.1 million in Q2 2026, $4.4 million in Q1 2026, and $4.2 million in Q4 2025.